{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:16Z","timestamp":1740124216918,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11255-021-02973-w","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T12:02:34Z","timestamp":1629115354000},"page":"1091-1096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytomegalovirus infection in patients with glomerular diseases treated with cyclophosphamide: a single-center prospective study"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7529-3010","authenticated-orcid":false,"given":"Gizem","family":"Kumru Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahin","family":"Eyupoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezzan","family":"Eren Sadioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gule","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Ates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehsuvar","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Nergizoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sule","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sim","family":"Kutlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Keven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"issue":"4","key":"2973_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"M Cannon","year":"2010","unstructured":"Cannon M, Schmid D, Hyde T (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20(4):202\u2013213. https:\/\/doi.org\/10.1002\/rmv.655","journal-title":"Rev Med Virol"},{"issue":"3","key":"2973_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P (2019) Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol 29(3):e2034. https:\/\/doi.org\/10.1002\/rmv.2034","journal-title":"Rev Med Virol"},{"issue":"1","key":"2973_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths P (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64(1):87\u201391. https:\/\/doi.org\/10.1093\/cid\/ciw668","journal-title":"Clin Infect Dis"},{"key":"2973_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104732","volume":"176","author":"P Griffiths","year":"2020","unstructured":"Griffiths P (2020) The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination. Antiviral Res 176:104732. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104732","journal-title":"Antiviral Res"},{"issue":"6","key":"2973_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A (2018) The Third International Consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102(6):900\u2013931. https:\/\/doi.org\/10.1097\/TP.0000000000002191","journal-title":"Transplantation"},{"issue":"12","key":"2973_CR6","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s11255-014-0849-0","volume":"46","author":"ZK Celebi","year":"2014","unstructured":"Celebi ZK, Calayoglu R, Yalc\u0131 AK, Akturk S, Sengul S, Kutlay S, Nergizoglu G, Erturk S, Duman N, Ates K, Keven K (2014) Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment. Int Urol Nephrol 46(12):2357\u20132360. https:\/\/doi.org\/10.1007\/s11255-014-0849-0","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"2973_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/nep.13071","volume":"23","author":"CC Lim","year":"2018","unstructured":"Lim CC, Tung YT, Tan BH, Lee PH, Mok I, Oon L, Chan KP, Choo JCJ (2018) Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology 23(7):676\u2013681. https:\/\/doi.org\/10.1111\/nep.13071","journal-title":"Nephrology"},{"issue":"8","key":"2973_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221793","volume":"14","author":"J Cui","year":"2019","unstructured":"Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A (2019) Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: a 10\u2212year single hospital experience. PLoS\u00a0One 14(8):e0221793. https:\/\/doi.org\/10.1371\/journal.pone.0221793","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"2973_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cid\/cit173","volume":"57","author":"N Durier","year":"2013","unstructured":"Durier N, Ananworanich J, Apornpong T, Ubolyam S, Kerr SJ, Mahanontharit A, Ferradini L, Ruxrungtham K, Avihingsanon A (2013) Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality. Clin Infect Dis 57(1):147\u2013155. https:\/\/doi.org\/10.1093\/cid\/cit173","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2973_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12879-017-2599-y","volume":"17","author":"LA Selvey","year":"2017","unstructured":"Selvey LA, Lim WH, Boan P, Swaminathan R, Slimings C, Harrison AE, Chakera A (2017) Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect Dis 17(1):501. https:\/\/doi.org\/10.1186\/s12879-017-2599-y","journal-title":"BMC Infect Dis"},{"issue":"12","key":"2973_CR11","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/lt.23540","volume":"18","author":"M Wadhawan","year":"2012","unstructured":"Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A (2012) Cytomegalovirus infection: Its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience. Liver Transplant 18(12):1448\u20131455. https:\/\/doi.org\/10.1002\/lt.23540","journal-title":"Liver Transplant"},{"issue":"3","key":"2973_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.transproceed.2011.11.053","volume":"44","author":"E Cordero","year":"2012","unstructured":"Cordero E, Casasola C, Ecarma R, Danguilan R (2012) Cytomegalovirus disease in kidney transplant recipients: Incidence, clinical profile, and risk factors. Transplant Proc 44(3):694\u2013700. https:\/\/doi.org\/10.1016\/j.transproceed.2011.11.053","journal-title":"Transplant Proc"},{"issue":"1","key":"2973_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12879-018-3195-5","volume":"18","author":"X Li","year":"2018","unstructured":"Li X, Huang Y, Xu Z, Zhang R, Liu X, Li Y, Mao P (2018) Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis 18(1):289. https:\/\/doi.org\/10.1186\/s12879-018-3195-5","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2973_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/eci.12410","volume":"45","author":"A Kronbichler","year":"2015","unstructured":"Kronbichler A, Jayne DRW, Mayer G (2015) Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest 45(3):346\u2013368. https:\/\/doi.org\/10.1111\/eci.12410","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"2973_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","volume":"47","author":"Y Takizawa","year":"2008","unstructured":"Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology 47(9):1373\u20131378. https:\/\/doi.org\/10.1093\/rheumatology\/ken231","journal-title":"Rheumatology"},{"issue":"4","key":"2973_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/ckj\/sfw101","volume":"10","author":"C Trivin","year":"2017","unstructured":"Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto J-F, Ficheux M, Vigneau C, Thervet E, Karras A (2017) Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J 10(4):461\u2013469. https:\/\/doi.org\/10.1093\/ckj\/sfw101","journal-title":"Clin Kidney J"},{"key":"2973_CR17","first-page":"282A","volume":"27","author":"D Chanouzas","year":"2016","unstructured":"Chanouzas D, Sagmeister M, Dyall L, Ferro C, Moss P, Morgan M, Harper L (2016) Valaciclovir to prevent cytomegalovirus mediated adverse modulation of the immune system in ANca Associated VASculitis (CANVAS): results of a randomised controlled clinical trial [Abstract no: TH-PO816]. J Am Soc Nephrol 27:282A","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2973_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/23744235.2019.1648855","volume":"51","author":"CC Lim","year":"2019","unstructured":"Lim CC, Tan BH, Tung YT, Huang H, Hao Y, Mok IYJ, Lee PH, Choo JCJ (2019) Risk-stratified approach to anti-viral prophylaxis against cytomegalovirus disease in glomerulonephritis and renal vasculitis treated with potent immunosuppressants. Infect Dis (Auckl) 51(10):745\u2013752. https:\/\/doi.org\/10.1080\/23744235.2019.1648855","journal-title":"Infect Dis (Auckl)"},{"issue":"7","key":"2973_CR19","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/art.30366","volume":"63","author":"M Morgan","year":"2011","unstructured":"Morgan M, Pachnio A, Begum J, Roberts D, Rasmussen N, Neil D, Bajema I, Savage C, Moss P, Harper L (2011) CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener\u2019s) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality. Arthritis Rheum 63(7):2127\u20132137. https:\/\/doi.org\/10.1002\/art.30366","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2973_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13075-018-1695-8","volume":"20","author":"D Chanouzas","year":"2018","unstructured":"Chanouzas D, Sagmeister M, Dyall L, Sharp P, Powley L, Johal S, Bowen J, Nightingale P, Ferro CJ, Morgan MD, Moss P, Harper L (2018) The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis. Arthritis Res Ther 20(1):194. https:\/\/doi.org\/10.1186\/s13075-018-1695-8","journal-title":"Arthritis Res Ther"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02973-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02973-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02973-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T17:26:33Z","timestamp":1649784393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02973-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2973"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02973-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the ethical committee of Ankara University and was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}}]}}